In this issue:
T-DXd plus durvalumab and platinum chemotherapy
Genetic properties allowing cancer cells to metastasise
Efficacy of first-line zongertinib
Can face age determine overall survival
Safety and efficacy of lorlatinib
Findings from ARROW study which investigated the efficacy and safety of pralsetinib
ResNet 3D-Pathology Fusion model
Stereotactic radiosurgery plus osimertinib
Clinical activity and safety of FMT plus immune checkpoint inhibitors
LDCT imaging and identifying osteoporosis
Please login below to download this issue (PDF)